Snowball logo
logo
LTGO

Latigo Biotherapeutics, Inc. Common Stock

LTGO • NASDAQ
$15.21-$0.05  (0.33%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20242025TTM
Revenue
Total revenue
---
COGS
---
Gross Profit
---
Operating Expenses & Income
Operating Income
(63.45)(110.4)(96.5)
Total Operating Expenses
63.45110.496.5
R&D Expenses
56.7899.5380.47
Selling General & Admin Expenses
6.66710.8616.03
Earnings from Continuing Operations
Interest Expense
--(0.251)
Interest Income
2.2642.9432.123
Income Tax Expense
---
Net Income
Net Income
(61.18)(109.2)(95.55)
Supplemental
EBIT
(63.45)(110.4)(96.33)
EBITDA
(63.21)(110.1)(96.1)
In millions of USD, except % and values per 1 share